WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人喘息患者に対する麻酔anesthesia for adult patients with asthma [show details]
… used. 15-methyl prostaglandin F₂alpha is used as a uterotonic agent for treatment of uterine atony. It is a bronchoconstrictor and should not be used in asthmatic patients . Although rare, there …
2. 鉄キレート薬：選択肢、投与量、副作用iron chelators choice of agent dosing and adverse effects [show details]
… chelating agents in wide use and a number of ways in which iron chelation therapy can be given in patients with transfusion-dependent thalassemia. Of importance, no agent or combination of agents is considered …
3. スルホニル尿素剤中毒sulfonylurea agent poisoning [show details]
…reviewed here. The therapeutic use of sulfonylureas and other antihyperglycemic agents, the toxicology of other antihyperglycemic agents such as metformin, and the general clinical management of drug intoxication …
4. 喘息におけるβ刺激剤：長期使用に関する議論beta agonists in asthma controversy regarding chronic use [show details]
… Reduced protection to bronchoconstrictor stimuli – Reduced protection against a bronchoconstrictor stimulus has also been studied.… pharmacologic agent to permit ICS dose reduction following its addition to a pre-existing ICS regimen. The efficacy of chronic LABAs as glucocorticoid-sparing agents was examined in…
5. 人工妊娠中絶に対するミソプロストール単独投与misoprostol as a single agent for medical termination of pregnancy [show details]
…mifepristone is not available or is too costly. In particular, misoprostol is commonly used as a single agent for second trimester induced abortion in the United States and many other parts of the world . This …

English Journal

Menthol inhibiting parasympathetic function of tracheal smooth muscle.

Wang HW1, Liu SC2, Chao PZ3, Lee FP3.
International journal of medical sciences.Int J Med Sci.2016 Nov 17;13(12):923-928. eCollection 2016.
PMID 27994497

Changes in inhaler inhalation acoustic features during induced bronchoconstriction: a pilot study.

McCartan TA, Taylor TE, Sulaiman I, Costello RW, Reilly RB.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference.Conf Proc IEEE Eng Med Biol Soc.2016 Aug;2016:3749-3752. doi: 10.1109/EMBC.2016.7591543.
Asthma is a chronic respiratory disease affecting millions of people worldwide, and is consequently a major issue for global health. Exacerbations are acute events involving the worsening of asthma's primary respiratory symptoms and are a major cause of morbidity in asthma patients, largely due to t
PMID 28269105

Exploring the mechanisms underpinning sweating: the development of a specialized ventilated capsule for use with intradermal microdialysis.

Meade RD1, Louie JC1, Poirier MP1, McGinn R1, Fujii N1, Kenny GP2.
Physiological reports.Physiol Rep.2016 Mar;4(6). pii: e12738. doi: 10.14814/phy2.12738. Epub 2016 Mar 31.
PMID 27033452

Japanese Journal

Trachea Relaxing Effects and β_2Selectivity of SPFF, a Newly Developed Bronchodilating Agent, in Guinea Pigs and Rabbits

Gan Le-Ling,Wang Min-Wei,Cheng Mao-Sheng [他],PAN Li
Biological & pharmaceutical bulletin 26(3), 323-328, 2003-03-01
… The protective effects of SPFF and salbutamol on bronchospasm induced by bronchoconstrictor aerosol in guinea pigs <i>in vivo</i> …
NAID 110003608426

Auscultation over the Neck during Bronchial Provocation Test in Asthmatics

Kusuhara Noriyuki,Abe Tadashi,Tomita Tomoyuki
北里医学 20(1), 66-73, 1990-02-28
… and 2) with listening to tracheal sounds as well as measuring Rrs, we can therefore perform the bronchial provocation test with smaller doses of bronchoconstrictor agent, more safely avoiding severe bronchoconstriction, and without much discomfort. …
NAID 110004704566

Ｉｎ　ｖｉｖｏにおけるイヌの気道に及ぼす血小板活性化因子（ＰＡＦ）の作用

三澤美和,高田立行
日本胸部疾患学会雑誌 26(7), 737-744, 1988
イヌにおいて気管支動脈潅流法を用い, PAFの気道平滑筋および気管支循環に対する作用を検討した. 気道平滑筋反応はPAF0.1μg i. a. 付近から収縮が発現し始め, 用量依存的にその強さを増した. Histamine に比べて数倍の活性を示した. 気管支循環反応については, PAFの用量が増すと気管支動脈血管床の潅流圧はいったん下降した後,持続的な昇圧反応に転じた. 全身血圧についても高用量 …
NAID 130003676326